Nephrology
| IgA nephropathy
Nephrology
IgA nephropathy
A Systematic Review and Network Meta-Analysis Comparing Efficacy and Safety of New Therapies for IgAN
book_2
Source:
Kidney Week 2024. Poster Session.
calendar_today
Published on Medfyle:
November 2024
In this medfyle
This Bayesian network meta-analysis presented at Kidney Week 2024 compared the efficacy of various treatments against placebo. Efficacy was ranked, finding that of current options – and based on data from 11 trials – mycophenolate and telitacicept are most effective in reducing UPCR and improving eGFR.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
©2024 Infomedica-Medfyle. All rights reserved.
Source: Comparative Efficacy and Safety of New Therapies for IgA Nephropathy: A Systematic Review and Network Meta-Analysis. de Lucena LA, et al. Presented at Kidney Week 2024; #FR-PO893.
The information and data provided is for information purposes only. The author(s) of the original original presentation had no involvement in the creation of this content.
